Raynaud’s phenomenon caused by cabergoline during the treatment of a macroprolactinoma: a case report

Autores/as

  • Laura González-Fernández
  • Roberto José Añez-Ramos
  • Alejandra Maricel Rivas-Montenegro
  • Diego Muñoz Moreno
  • Juan Carlos Percovich-Hualpa

Palabras clave:

Raynaud, vasospasm, cabergoline, case report, adverse effects

Resumen

Digital vasospasm is a known adverse effect of dopamine agonists such as bromocriptine; however, it has rarely been reported with cabergoline. We describe a case of Raynaud's phenomenon as a side effect of treatment with the latter in a 52-year-old woman with a macroprolactinoma, forcing discontinuation. In this context, we conducted a review of the literature, with emphasis on the possible criteria for discontinuation of treatment with dopaminergic agonists in patients with macroprolactinoma.

Descargas

Los datos de descargas todavía no están disponibles.

Descargas